The 2010 Schedule is as follows:     April 19th, University of Pennsylvania hosted by Professor Benkovic     July 22nd, University of Illinois hosted by Professor Zhao     October — UFRFI, hosted by Professor Ingram. Date has not been confirmed     December 10th — Myriant Technologies, Date is tentative.3. Term and Termination. This Agreement shall become effective on the date hereof and shallremain in force for a term of three (3) years. This Agreement shall be renewable for additionalthree (3) year terms, at the invitation of the Company and the acceptance of the Advisor.Furthermore, this Agreement may be terminated, in writing, by either the Company or the Advisor, atany time and for any reason.4. Compensation. Upon execution of the Agreement, the Advisor will receive compensation ofrestricted stock having an initial value of Twenty Five Thousand Dollars (US $25,000) and everyyear thereafter during their term as long as the company is an LLC. Upon establishment of theproposed C-corporation as the parent of the Company, the annual stipend thereafter will consist ofa value of Twenty Five Thousand Dollar (US $25,000) to be comprised of (a) sixty percent (60%) ofequity in the parent company; and forty percent (40%) in cash. In addition, the Advisor shallreceive Two Thousand Dollars ($2000) per meeting day for attendance at any of the ScientificAdvisory Panel meetings.5. Expenses. The Advisor shall be entitled to reimbursement from the Company for allreasonable out-of-pocket expenses incurred in connection with its services to the ScientificAdvisory Panel, upon presentation to the Company of written documentation for such expenses.6. Inventions. Advisor agrees to disclose in writing to the Company all inventions,improvements and other innovations related to the development and commercialization ofbiorefineries for the production of high-value bio-based chemicals and fuels from renewablefeedstock through the use of its proprietary biocatalyst technology that Advisor may make orconceive in the course of serving a member of the Company’s Scientific Advisory Panel, if they arerelated to his or her scientific and business work for the Company and whether or not they areeligible for patent, copyright, trademark, trade secret or other legal protection(“Innovations”). Advisor hereby assigns all her rights in the Innovations to the Company.At the Company’s request and expense, during and after the period of Advisor’s consultingarrangements with the Company, Advisor agrees to assist and cooperate with the Company in allrespects and will execute documents, and, subject to his or her reasonable availability, givetestimony and take further acts requested by the Company to obtain for the Company, maintain andenforce patent, copyright, trademark, trade secrets and other legal protection for the Innovations.7. Confidential Information. The Advisor acknowledges that the Advisor may be furnished orgiven access to certain non-public information of commercial or other value to the business inwhich the Company is engaged (the “Confidential Information”) during the term of thisappointment. The Advisor further acknowledges that Confidential Information constitutes a

 
proprietary right that the Company is entitled to protect. Accordingly, the Advisor agrees thatduring the term of this Agreement and thereafter until such time as all the ConfidentialInformation becomes publicly known and made generally available through no action or inaction ofthe Advisor, the Advisor will keep in strict confidence the Confidential Information and shall not,without prior written consent of the Company in each instance, disclose, use or otherwisedisseminate the Confidential Information, directly or indirectly, to any third party.8. Indemnification. The Advisor shall have no obligations or liabilities, other than thoseidentified in Sections 6 and 7 herein, for any actions or omissions taken as an Advisor. AnyAdvisor who is made, or threatened to be made, a party to any pending action or proceeding, whethercivil, criminal, administrative or investigative, arising out of or related to the Advisor’sservice on the Scientific Advisory Panel, shall be indemnified by the Company and the Company shalladvance to the Advisor such related expenses incurred in defense of such action to the fullestextent permitted by applicable law. The Company shall make any indemnification payment, includingany payment of defense costs, promptly after request by Advisor. For the purposes hereof, Advisorshall include such Advisor’s heirs and personal representatives. The Company further acknowledgesthat the foregoing indemnification is a material inducement for the Advisor to serve on theScientific Advisory Panel and that the Advisor would not otherwise agree to serve on the ScientificAdvisory Panel in the absence of this inducement. This Section 8 shall survive the termination ofthis Agreement.     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date hereof.Myriant Technologies, LLC     By:              [Advisor]       By: